SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001720725-22-000009
Filing Date
2022-01-21
Accepted
2022-01-21 17:14:29
Documents
5
Effectiveness Date
2022-01-21

Document Format Files

Seq Description Document Type Size
1 S-8 a2022s-8form.htm S-8 87258
2 EX-5.1 oysterpoint-2021formsx8202.htm EX-5.1 9381
3 EX-23.1 oysts-8consentdraftv1182022.htm EX-23.1 2597
4 EX-99.2 oysterpointpharmainc-emplo.htm EX-99.2 141092
5 image_1.jpg GRAPHIC 8359
  Complete submission text file 0001720725-22-000009.txt   252988
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262291 | Film No.: 22546755
SIC: 2836 Biological Products, (No Diagnostic Substances)